194 related articles for article (PubMed ID: 34249736)
1. Predicting Severe Radiation Esophagitis in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma Receiving Definitive Chemoradiotherapy: Construction and Validation of a Model Based in the Clinical and Dosimetric Parameters as Well as Inflammatory Indexes.
Yu Y; Zheng H; Liu L; Li H; Zheng Q; Wang Z; Wu Y; Li J
Front Oncol; 2021; 11():687035. PubMed ID: 34249736
[TBL] [Abstract][Full Text] [Related]
2. Using inflammatory indexes and clinical parameters to predict radiation esophagitis in patients with small-cell lung cancer undergoing chemoradiotherapy.
Qiu J; Ke D; Lin H; Yu Y; Zheng Q; Li H; Zheng H; Liu L; Li J
Front Oncol; 2022; 12():898653. PubMed ID: 36483030
[TBL] [Abstract][Full Text] [Related]
3. A nomogram to predict short-term outcome of radiotherapy or chemoradiotherapy based on pre/post-treatment inflammatory biomarkers and their dynamic changes in esophageal squamous cell carcinoma.
Liang S; Li C; Gao Z; Li J; Zhao H; Yu J; Meng X
Int Immunopharmacol; 2021 Jan; 90():107178. PubMed ID: 33218939
[TBL] [Abstract][Full Text] [Related]
4. Nomogram based on circulating lymphocyte subsets for predicting radiation pneumonia in esophageal squamous cell carcinoma.
Zhang XZ; Tao SP; Liang SX; Chen SB; Liu FS; Jiang W; Chen MJ
Front Immunol; 2022; 13():938795. PubMed ID: 36105795
[TBL] [Abstract][Full Text] [Related]
5. A nomogram for the predicting of survival in patients with esophageal squamous cell carcinoma undergoing definitive chemoradiotherapy.
Wang P; Yang M; Wang X; Zhao Z; Li M; Yu J
Ann Transl Med; 2021 Feb; 9(3):233. PubMed ID: 33708860
[TBL] [Abstract][Full Text] [Related]
6. Pretreatment Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Factors and Reference Markers of Treatment Options for Locally Advanced Squamous Cell Carcinoma Located in the Middle and Upper Esophagus.
Wang C; Tong J; Tang M; Lu Y; Liang G; Zhang Z; Chen T
Cancer Manag Res; 2021; 13():1075-1085. PubMed ID: 33574705
[TBL] [Abstract][Full Text] [Related]
7. Nomogram-Integrated C-Reactive Protein/Albumin Ratio Predicts Efficacy And Prognosis In Patients With Thoracic Esophageal Squamous Cell Carcinoma Receiving Chemoradiotherapy.
Zhang H; Guo XW; Yin XX; Liu YC; Ji SJ
Cancer Manag Res; 2019; 11():9459-9468. PubMed ID: 31819611
[TBL] [Abstract][Full Text] [Related]
8. A nomogram based on hematological markers to predict radiosensitivity in patients with esophageal squamous cell carcinoma.
Sun L; Wei P; Ge S; Zheng J; Ye S; Zhang Y
Medicine (Baltimore); 2023 Mar; 102(11):e33282. PubMed ID: 36930089
[TBL] [Abstract][Full Text] [Related]
9. Predicting severe acute radiation pneumonitis in patients with non-small cell lung cancer receiving postoperative radiotherapy: Development and internal validation of a nomogram based on the clinical and dose-volume histogram parameters.
Tang X; Li Y; Tian X; Zhou X; Wang Y; Huang M; Ren L; Zhou L; Xue J; Ding Z; Zhu J; Xu Y; Peng F; Wang J; Lu Y; Gong Y
Radiother Oncol; 2019 Mar; 132():197-203. PubMed ID: 30385172
[TBL] [Abstract][Full Text] [Related]
10. A Novel Nomogram Model Based on Cone-Beam CT Radiomics Analysis Technology for Predicting Radiation Pneumonitis in Esophageal Cancer Patients Undergoing Radiotherapy.
Du F; Tang N; Cui Y; Wang W; Zhang Y; Li Z; Li J
Front Oncol; 2020; 10():596013. PubMed ID: 33392091
[TBL] [Abstract][Full Text] [Related]
11. Lymphocyte-monocyte ratio as a predictive marker for pathological complete response to neoadjuvant therapy in esophageal squamous cell carcinoma.
Zhao K; Wang C; Shi F; Li M; Yu J
Transl Cancer Res; 2020 Jun; 9(6):3842-3853. PubMed ID: 35117751
[TBL] [Abstract][Full Text] [Related]
12. Predictive model of the first failure pattern in patients receiving definitive chemoradiotherapy for inoperable locally advanced non-small cell lung cancer (LA-NSCLC).
Zhu X; Hou R; Li X; Jiang C; Xia W; Fu X
Radiat Oncol; 2020 Feb; 15(1):43. PubMed ID: 32070383
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of systemic immune-inflammation index for pathological complete response in patients receiving neoadjuvant immunochemotherapy for locally advanced esophageal cancer.
Han W; Weng K; Zhang P; Hong Z
Front Surg; 2022; 9():1091601. PubMed ID: 36684142
[TBL] [Abstract][Full Text] [Related]
14. Nomogram for predicting pathologic complete response to neoadjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma.
Liu G; Chen T; Zhang X; Hu B; Yu J
Cancer Med; 2024 Mar; 13(5):e7075. PubMed ID: 38477511
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a novel nomogram for predicting systemic inflammatory response syndrome's occurrence in patients undertaking flexible ureteroscopy.
Xuan Z; Yu Z; Tan G; Ding N; He H; Yu S; Liu G; Zhu X; Zhu B; Liu Z
Transl Androl Urol; 2022 Feb; 11(2):228-237. PubMed ID: 35280653
[TBL] [Abstract][Full Text] [Related]
16. CT-based radiomics combined with hematologic parameters for survival prediction in locally advanced esophageal cancer patients receiving definitive chemoradiotherapy.
Cui J; Zhang D; Gao Y; Duan J; Wang L; Li L; Yuan S
Insights Imaging; 2024 Mar; 15(1):87. PubMed ID: 38523188
[TBL] [Abstract][Full Text] [Related]
17. Prediction of Pathologic Response to Neoadjuvant Chemoradiotherapy in Patients with Esophageal Squamous Cell Carcinoma Incorporating Hematological Biomarkers.
Wu Y; Chen J; Zhao L; Li Q; Zhu J; Yang H; Guo S; Xi M
Cancer Res Treat; 2021 Jan; 53(1):172-183. PubMed ID: 32898941
[TBL] [Abstract][Full Text] [Related]
18. Clinical and Dosimetric Predictors for Postoperative Cardiopulmonary Complications in Esophageal Squamous Cell Carcinoma Patients Receiving Neoadjuvant Chemoradiotherapy and Surgery.
Liang Z; Luo K; Wang Y; Zeng Q; Ling X; Wang S; Dragomir MP; Li Q; Yang H; Xi M; Chen B
Ann Surg Oncol; 2023 Jan; 30(1):529-538. PubMed ID: 36127527
[TBL] [Abstract][Full Text] [Related]
19. A nomogram based on pretreatment CT radiomics features for predicting complete response to chemoradiotherapy in patients with esophageal squamous cell cancer.
Luo HS; Huang SF; Xu HY; Li XY; Wu SX; Wu DH
Radiat Oncol; 2020 Oct; 15(1):249. PubMed ID: 33121507
[TBL] [Abstract][Full Text] [Related]
20. Predicting Prognosis and Adverse Events by Hematologic Markers in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemoradiotherapy.
Cai G; Yu J; Meng X
Cancer Manag Res; 2020; 12():8497-8507. PubMed ID: 33061564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
